blindness glp 1 Seeing scary posts about GLP-1 medications and vision changes? Here’s where more nuance matters., Current evidence does not show a simple “GLP-1s cause blindness” story. Reported eye concerns often Lipsitz, Ponterio & Comerford |

The genetic test reveals predispositions in peptide and metabolic pathways, not exact medication response

When you stop retatrutide, glucagon receptor stimulation ends and metabolic rate returns to baseline

In the Phase 3 TRIUMPH-1 obesity trial, patients on the highest dose lost an average of 70.3 pounds, or 28.3% of body weight, over 80 weeks

Lower Risk of Weight Regain Prevents rebound weight gain when combined with lifestyle changes

Although the effectiveness of current GLP-1 agonists has been demonstrated, there are some side-effects associated with their use gastrointestinal issues such as nausea, vomiting, and mental health changes like anxiety and irritability, she notes

Immunofluorescence examination of the spinal cord revealed that teneligliptin inhibited the immunoreactivity of glial fibrillary acidic protein, indicating that its analgesic effects are associated with the suppression of spinal astrocyte activation thereby preventing neuroinflammation [70]